A study in the US has flagged serious adverse events linked to long-term use of gabapentin and pregabalin, which are widely prescribed to treat diabetic neuropathy. Viatris, the market leader, has disputed the study and downplayed the risks. While doctors have called for a closer study and a vigilance programme, what should be the course of action meanwhile?
Canadian physician William Osler is said to have once remarked that medicine is a science of uncertainty and an art of probability. The quote by Osler, known as the father of modern medicine, has of late been recalled during discussions among doctors in light of a study associated with two widely prescribed drugs used to treat diabetic neuropathy. The condition affects diabetes patients who have nerve-tissue damage that manifests in severe pain,
10 mins read, Last Updated: Jan 19, 2023, 07:33 PM IST
Gift A Story
Share member-only stories with your friends or family and help them read it for free.
Gifting Limit Reached!
Hey , no more stories left for you to gift.
No worries! You will get a limit of 15 stories next month to share with your friends and family.
Gift This Story
You can gift upto 15 stories in a month.
- FONT SIZE